Soltego is a biotechnology company utilizing salt-inducible kinase (SIK) inhibitors to enhance the skin's natural defenses against sun-induced damage and photoaging. By activating physiological processes related to melanin and collagen, Soltego's formulations aim to improve skin health and appearance, providing a proactive solution for individuals exposed to harmful UV rays.
Funding
Funding not disclosed
Founders
Product
Problem
Sunscreens alone may not provide complete protection against sun-induced skin damage, and individuals seek additional defenses against UV radiation and environmental stressors. Photoaging, resulting from UV exposure, leads to collagen and elastin damage, causing wrinkles and impacting skin health and appearance.
Solution
Soltego utilizes salt-inducible kinase (SIK) inhibitors to activate the skin's natural biological pathways, enhancing its defenses against sun damage and photoaging. By stimulating melanin and collagen production, Soltego's formulations aim to improve skin health, radiance, and overall appearance. The topical application of SIK inhibitors helps repair and rejuvenate skin damaged by sun exposure, promoting a healthier and more vibrant complexion. Soltego's approach offers a proactive solution for individuals seeking to mitigate the effects of UV rays and maintain youthful-looking skin.
Target Audience
The primary target audience includes individuals concerned about sun protection, photoaging, and maintaining healthy, youthful-looking skin, as well as those seeking scientifically-backed skincare products to address sun damage and environmental stressors.
Features
- Formulations leverage salt-inducible kinase (SIK) inhibitors to activate physiological activities on melanin and collagen production.
- Designed to work with the body's natural biological pathways to protect against sun-induced damage.
- Aims to improve skin appearance and overall well-being by repairing and rejuvenating sun-damaged skin.
- Offers an extra line of defense against environmental stressors, complementing sunscreen use.
- Products are developed based on over 10 years of research, clinical studies, and formulations.
- Holds multiple patents related to the use of SIK inhibitors in skincare.